Chemidox Clinical Trials Incorporated

Lancaster, California 93534

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis

Studies at this site

• A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) — Completed
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early